Population Pharmacokinetics and Exposure–Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease
- Resource Type
- Article
- Source
- In
Clinical Therapeutics October 2022 44(10):1336-1355 - Subject
- Language
- ISSN
- 0149-2918